Dario Renato Alessi (born 1967) is a French-born British biochemist, Director of the Medical Research Council Protein Phosphorylation and Ubiquitylation Unit (MRC PPU) and Professor of Signal Transduction, at the School of Life Sciences, University of Dundee.
He graduated from the University of Birmingham, with a Bachelor of Science in biochemistry in 1988, and with a PhD in 1991, where he studied with Ian Trayer and David Trentham.
[8][9] Alessi's work is concerned with unravelling the roles of poorly characterised components that regulate protein phosphorylation or ubiquitylation that have emerged from the genetic analysis of human disease.
[2] Dario Alessi is also the current Director of the Division of Signal Transduction Therapy Unit (DSTT) which is a unique collaboration between University of Dundee and six major pharmaceutical companies (AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline GlaxoSmithKline, Merck KGaA, Janssen Pharmaceuticals and Pfizer) that aims to accelerate drug discovery in the areas of protein phosphorylation and ubiquitylation.
[14] [15] Alessi was appointed Officer of the Order of the British Empire (OBE) in the 2023 Birthday Honours for services to biomedical research and translation.